Glycopyrrolate 1 mg/1 (Glycopyrrolate TABLET) 1 mg/1

Glycopyrrolate 1 mg tablets are anticholinergic medications used to reduce secretions and manage certain gastrointestinal conditions. This oral medication is available in 100 blister packs per carton.

Strength

1 mg/1

Pack Size

100 BLISTER PACK in 1 CARTON (0904-6709-61) / 1 TABLET in 1 BLISTER PACK

Manufacturer / TM Owner

Major Pharmaceuticals

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Glycopyrrolate is commonly used to manage excessive secretions and symptoms related to gastrointestinal disorders. It works by blocking certain nerve signals that trigger these conditions. People often ask, 'What is Glycopyrrolate used for?' and the answer includes its role in reducing stomach acid and managing conditions like peptic ulcers.

Side Effects

Common effects of Glycopyrrolate may include dry mouth, blurred vision, and constipation. Some users also report dizziness or drowsiness. These effects can vary depending on individual tolerance and the specific condition being treated.

Precautions & Warnings

Glycopyrrolate should be handled with care, especially by individuals with certain medical conditions like glaucoma or urinary retention. It is important to follow the advice of a healthcare provider regarding its use. Always store the medication in a cool, dry place away from direct sunlight.

Avoid Interactions

Glycopyrrolate may interact with other medications, including anticholinergics and certain antidepressants. It is advisable to consult a healthcare provider before combining Glycopyrrolate with other drugs. Additionally, alcohol consumption should be avoided as it may enhance the sedative effects.

Frequently Asked Questions

Glycopyrrolate is primarily used to reduce secretions and manage gastrointestinal conditions by blocking certain nerve signals.

Glycopyrrolate tablets should be stored in a cool, dry place away from direct sunlight and out of reach of children.

Common side effects include dry mouth, blurred vision, constipation, dizziness, and drowsiness.

Glycopyrrolate may interact with other medications, so it is important to consult a healthcare provider before combining it with other drugs.

Glycopyrrolate should be used with caution in individuals with certain medical conditions like glaucoma or urinary retention.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.